vs

Side-by-side financial comparison of OCULAR THERAPEUTIX, INC (OCUL) and Terra Property Trust, Inc. (TPTA). Click either name above to swap in a different company.

OCULAR THERAPEUTIX, INC is the larger business by last-quarter revenue ($13.3M vs $7.1M, roughly 1.9× Terra Property Trust, Inc.). Terra Property Trust, Inc. runs the higher net margin — -150.2% vs -488.0%, a 337.8% gap on every dollar of revenue. On growth, OCULAR THERAPEUTIX, INC posted the faster year-over-year revenue change (-22.4% vs -37.4%). Over the past eight quarters, OCULAR THERAPEUTIX, INC's revenue compounded faster (-5.3% CAGR vs -31.3%).

Ocular Therapeutix, Inc. is a biopharmaceutical firm specializing in developing and commercializing innovative ophthalmic therapies. Its products treat acute and chronic eye conditions including post-surgical pain, glaucoma, and dry eye, serving patients and ophthalmology providers primarily across the U.S. and select global markets.

The National Savings and Trust Company is a historic bank building located at the corner of New York Avenue and 15th Street, NW in Downtown Washington, D.C. It has also been known as the National Safe Deposit Company and the National Safe Deposit Savings and Trust Company.

OCUL vs TPTA — Head-to-Head

Bigger by revenue
OCUL
OCUL
1.9× larger
OCUL
$13.3M
$7.1M
TPTA
Growing faster (revenue YoY)
OCUL
OCUL
+14.9% gap
OCUL
-22.4%
-37.4%
TPTA
Higher net margin
TPTA
TPTA
337.8% more per $
TPTA
-150.2%
-488.0%
OCUL
Faster 2-yr revenue CAGR
OCUL
OCUL
Annualised
OCUL
-5.3%
-31.3%
TPTA

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
OCUL
OCUL
TPTA
TPTA
Revenue
$13.3M
$7.1M
Net Profit
$-64.7M
$-10.6M
Gross Margin
88.0%
Operating Margin
-526.5%
-48.8%
Net Margin
-488.0%
-150.2%
Revenue YoY
-22.4%
-37.4%
Net Profit YoY
-33.6%
32.0%
EPS (diluted)
$-0.27
$-0.43

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OCUL
OCUL
TPTA
TPTA
Q4 25
$13.3M
$7.1M
Q3 25
$14.5M
$7.3M
Q2 25
$13.5M
$8.6M
Q1 25
$10.7M
$12.5M
Q4 24
$17.1M
$11.3M
Q3 24
$15.4M
$12.2M
Q2 24
$16.4M
$11.2M
Q1 24
$14.8M
$15.0M
Net Profit
OCUL
OCUL
TPTA
TPTA
Q4 25
$-64.7M
$-10.6M
Q3 25
$-69.4M
$-6.7M
Q2 25
$-67.8M
$-9.2M
Q1 25
$-64.1M
$-1.3M
Q4 24
$-48.4M
$-15.6M
Q3 24
$-36.5M
$-7.8M
Q2 24
$-43.8M
$-7.5M
Q1 24
$-64.8M
$-6.2M
Gross Margin
OCUL
OCUL
TPTA
TPTA
Q4 25
88.0%
Q3 25
87.8%
Q2 25
85.6%
Q1 25
88.2%
Q4 24
92.8%
Q3 24
89.9%
Q2 24
90.8%
Q1 24
91.0%
Operating Margin
OCUL
OCUL
TPTA
TPTA
Q4 25
-526.5%
-48.8%
Q3 25
-472.3%
6.7%
Q2 25
-502.6%
-28.4%
Q1 25
-597.5%
32.8%
Q4 24
-296.1%
-72.3%
Q3 24
-298.2%
54.1%
Q2 24
-265.1%
6.3%
Q1 24
-214.0%
32.0%
Net Margin
OCUL
OCUL
TPTA
TPTA
Q4 25
-488.0%
-150.2%
Q3 25
-477.3%
-92.4%
Q2 25
-503.9%
-106.5%
Q1 25
-598.7%
-10.3%
Q4 24
-283.3%
-138.3%
Q3 24
-236.6%
-63.9%
Q2 24
-266.3%
-67.5%
Q1 24
-438.9%
-41.2%
EPS (diluted)
OCUL
OCUL
TPTA
TPTA
Q4 25
$-0.27
$-0.43
Q3 25
$-0.38
$-0.28
Q2 25
$-0.39
$-0.38
Q1 25
$-0.38
$-0.05
Q4 24
$-0.25
$-0.65
Q3 24
$-0.22
$-0.32
Q2 24
$-0.26
$-0.31
Q1 24
$-0.49
$-0.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OCUL
OCUL
TPTA
TPTA
Cash + ST InvestmentsLiquidity on hand
$737.1M
$33.2M
Total DebtLower is stronger
$178.9M
Stockholders' EquityBook value
$654.3M
$146.5M
Total Assets
$808.1M
$351.5M
Debt / EquityLower = less leverage
1.22×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OCUL
OCUL
TPTA
TPTA
Q4 25
$737.1M
$33.2M
Q3 25
$344.8M
$17.4M
Q2 25
$391.1M
$5.9M
Q1 25
$349.7M
$11.9M
Q4 24
$392.1M
$8.6M
Q3 24
$427.2M
$21.2M
Q2 24
$459.7M
$18.9M
Q1 24
$482.9M
$17.9M
Total Debt
OCUL
OCUL
TPTA
TPTA
Q4 25
$178.9M
Q3 25
$211.9M
Q2 25
$260.2M
Q1 25
$286.7M
Q4 24
$326.1M
Q3 24
$312.9M
Q2 24
$383.8M
Q1 24
$377.6M
Stockholders' Equity
OCUL
OCUL
TPTA
TPTA
Q4 25
$654.3M
$146.5M
Q3 25
$258.2M
$159.7M
Q2 25
$305.9M
$168.5M
Q1 25
$265.9M
$179.9M
Q4 24
$315.3M
$185.7M
Q3 24
$352.0M
$206.2M
Q2 24
$377.7M
$218.6M
Q1 24
$408.0M
$230.5M
Total Assets
OCUL
OCUL
TPTA
TPTA
Q4 25
$808.1M
$351.5M
Q3 25
$410.9M
$398.1M
Q2 25
$451.3M
$459.3M
Q1 25
$405.9M
$495.2M
Q4 24
$457.9M
$542.8M
Q3 24
$490.4M
$546.8M
Q2 24
$517.1M
$634.4M
Q1 24
$538.9M
$640.2M
Debt / Equity
OCUL
OCUL
TPTA
TPTA
Q4 25
1.22×
Q3 25
1.33×
Q2 25
1.54×
Q1 25
1.59×
Q4 24
1.76×
Q3 24
1.52×
Q2 24
1.76×
Q1 24
1.64×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OCUL
OCUL
TPTA
TPTA
Operating Cash FlowLast quarter
$-54.2M
$1.9M
Free Cash FlowOCF − Capex
$-57.1M
FCF MarginFCF / Revenue
-430.9%
Capex IntensityCapex / Revenue
21.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-216.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OCUL
OCUL
TPTA
TPTA
Q4 25
$-54.2M
$1.9M
Q3 25
$-50.7M
$-4.3M
Q2 25
$-55.2M
$1.2M
Q1 25
$-44.7M
$861.6K
Q4 24
$-39.4M
$-3.3M
Q3 24
$-36.6M
$1.7M
Q2 24
$-24.8M
$-3.1M
Q1 24
$-33.9M
$-4.2M
Free Cash Flow
OCUL
OCUL
TPTA
TPTA
Q4 25
$-57.1M
Q3 25
$-56.7M
Q2 25
$-56.5M
Q1 25
$-46.6M
Q4 24
$-39.6M
Q3 24
$-36.6M
Q2 24
$-25.5M
Q1 24
$-34.1M
FCF Margin
OCUL
OCUL
TPTA
TPTA
Q4 25
-430.9%
Q3 25
-390.0%
Q2 25
-419.7%
Q1 25
-435.6%
Q4 24
-232.0%
Q3 24
-237.6%
Q2 24
-155.4%
Q1 24
-231.1%
Capex Intensity
OCUL
OCUL
TPTA
TPTA
Q4 25
21.4%
Q3 25
41.2%
Q2 25
9.3%
Q1 25
18.1%
Q4 24
1.2%
0.0%
Q3 24
0.6%
Q2 24
4.5%
Q1 24
1.7%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons